UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
BMS at crossroads with mixed Opdivo-Yervoy trial results
Bristol-Myers Squibb (NYSE: BMY) announced Tuesday mixed results from its O...
by Marian Chu
|
2017-08-17 11:24
라인
Pfizer criticized for steep price hikes in global markets
Pfizer has come under fire in many countries for hiking up drug prices, and...
by Marian Chu
|
2017-08-17 08:53
라인
Amgen Korea releases high-cholesterol treatment
Amgen Korea암젠코리아 has released Repatha (component: evolocumab), a treatment ...
by Constance Williams
|
2017-08-16 17:19
라인
Drug industry’s market value showed mixed results
The aggregate market value of pharmaceutical industry increased more than 9...
by Nam Doo-hyun
|
2017-08-16 17:10
라인
Patent expiry of Lyrica, Tamiflu heats up generic market
The patents of painkiller Lyrica and influenza therapy Tamiflu with annual ...
by Lee Hye-seon
|
2017-08-16 16:36
라인
Daewoong launches Lyrica’s generic for neuropathic pain
Daewoong Pharmaceutical대웅제약 (CEO: Lee Jong-wook이종욱) has released a neuropat...
by Marian Chu
|
2017-08-16 10:30
라인
Green Cross steps up localization of tuberculosis vaccine
Green Cross has won the approval of phase 1 clinical trial plan of BCG vacc...
by Lee Hye-seon
|
2017-08-14 17:13
라인
Gilead’s hepatitis B therapy to vie with 20 Korean therapies
Korea has approved 20 products made by Korean companies targeting for No.1 ...
by Lee Hye-seon
|
2017-08-14 11:54
라인
4 Korean pharmaceuticals make waves in immunotherapy market
Korean pharmaceutical companies are catching up in the immunotherapy market...
by Marian Chu
|
2017-08-12 06:00
라인
Ministry designates 2 new orphan drugs
The Ministry of Food and Drug Safety designated Nusinersen and Tacrolimus a...
by Marian Chu
|
2017-08-11 16:55
라인
Hanmi to recruit 200 employees in bio, R&D sector
Hanmi Pharmaceuticals said Friday it plans to recruit 200 people in the sec...
by Constance Williams
|
2017-08-11 16:05
라인
‘Moon Jae-in care’ keeps industry busy weighing bottom lines
After President Moon Jae-in announced a policy to drastically expand health...
by Park Gi-taek
|
2017-08-11 13:42
라인
Daewoong launches venous insufficiency drug
Daewoong Pharmaceuticals대웅제약 (CEO Lee Jong-wook이종욱) has launched Centelight...
by Constance Williams
|
2017-08-11 10:59
라인
LG Chem releases sharply improved reagent
LG ChemLG화학 has launched a reagent that can check 93 allergy-causing substa...
by Constance Williams
|
2017-08-10 17:29
라인
Chong Kun Dang announces ‘employee-happy’ management plan
Chong Kun Dang has introduced an “employee-happiness” management system to ...
by Marian Chu
|
2017-08-10 17:29
라인
Korea United gets patent for combined oral formulation tech
Korea United Pharmaceuticals has recently registered a patent for its combi...
by Constance Williams
|
2017-08-10 11:04
라인
Regulators to add cautions against Loxoprofen
The Ministry of Food and Drug Safety (MFDS) will add the warnings of shock ...
by Lee Hye-seon
|
2017-08-09 18:53
라인
Jeil Pharmaceuticals launches ‘global smart factory’
Jeil Pharmaceuticals has begun the operation of its “state-of-the-art globa...
by Constance Williams
|
2017-08-09 12:39
라인
Novartis’ anti-arthritis drug to get insurance benefits
Novartis Korea announced Tuesday that its anti-arthritis drug Cosentyx (ing...
by Constance Williams
|
2017-08-08 16:34
라인
Dong-A Socio chairman arrested for embezzlement, tax avoidance
Dong-A Socio Holdings Chairman Kang Jung-seok was arrested Monday for embez...
by Marian Chu
|
2017-08-08 16:11
-
이전
111
112
113
114
115
116
117
118
119
120
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top